P-416 A Multicenter Observational Retrospective Study of Second-Line Treatment with Daratumumab–Bortezomib–Dexamethasone (daravd) in Multiple Myeloma (MM) Patients Refractory to Lenalidomide
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined